These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19386072)

  • 41. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance training in patients with end-stage renal disease.
    Völker K
    Clin Nephrol; 2004 May; 61 Suppl 1():S51-3. PubMed ID: 15233248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Sardh E; Andersson DE; Henrichson A; Harper P
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):66-71. PubMed ID: 19268004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapy Insight: sexual dysfunction in patients with chronic kidney disease.
    Finkelstein FO; Shirani S; Wuerth D; Finkelstein SH
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):200-7. PubMed ID: 17389889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular problems in the patient with end-stage renal disease.
    Mullaem G; Rosner MH
    Semin Dial; 2012 Jul; 25(4):403-7. PubMed ID: 22686705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dialysis and the elderly: an underestimated problem.
    Buemi M; Lacquaniti A; Bolignano D; Donato V; Fazio MR; Campo S; Coppolino G; Sturiale A
    Kidney Blood Press Res; 2008; 31(5):330-6. PubMed ID: 18936550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Starting and managing an intradialytic exercise program.
    Bayliss D
    Nephrol News Issues; 2006 Aug; 20(9):47-9. PubMed ID: 16916063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of nephrologist in treatment of multiple myeloma].
    Kes P; Basić-Jukić N; Jurić I; Brunetta B
    Acta Med Croatica; 2008; 62 Suppl 1():37-43. PubMed ID: 18578331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.
    Fraser CL; Arieff AI
    New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment strategies for peripheral artery disease.
    McCann AB; Jaff MR
    Expert Opin Pharmacother; 2009 Jul; 10(10):1571-86. PubMed ID: 19527186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review article: Tackling the survival issue in end-stage renal disease: time to get physical on haemodialysis.
    Cheema BS
    Nephrology (Carlton); 2008 Oct; 13(7):560-9. PubMed ID: 19161363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of endurance training on extrarenal potassium regulation and exercise performance in patients on haemodialysis.
    Petersen AC; Leikis MJ; McMahon LP; Kent AB; McKenna MJ
    Nephrol Dial Transplant; 2009 Sep; 24(9):2882-8. PubMed ID: 19389866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the primary care physician in diagnosis and treatment of early renal damage.
    Cueto-Manzano AM; Cortés-Sanabria L; Martínez-Ramírez HR
    Ethn Dis; 2009; 19(1 Suppl 1):S1-68-72. PubMed ID: 19484880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Metabolic neuropathies].
    Lozeron P; Adams D
    Rev Prat; 2008 Nov; 58(17):1903-9. PubMed ID: 19157206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Barriers and facilitators for engagement and implementation of exercise in end-stage kidney disease: Future theory-based interventions using the Behavior Change Wheel.
    Clarke AL; Jhamb M; Bennett PN
    Semin Dial; 2019 Jul; 32(4):308-319. PubMed ID: 30937975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise and cognitive function in patients with end-stage kidney disease.
    Chu NM; McAdams-DeMarco MA
    Semin Dial; 2019 Jul; 32(4):283-290. PubMed ID: 30903625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exercise and dialysis.
    Johansen KL
    Hemodial Int; 2008 Jul; 12(3):290-300. PubMed ID: 18638081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Midodrine-induced vascular ischemia in a hemodialysis patient: a case report and literature review.
    Rubinstein S; Haimov M; Ross MJ
    Ren Fail; 2008; 30(8):808-12. PubMed ID: 18791956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quinine--a tonic too bitter for hemodialysis-associated muscle cramps?
    Kobrin SM; Berns JS
    Semin Dial; 2007; 20(5):396-401. PubMed ID: 17897243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rehabilitation management of neuromuscular disease: the role of exercise training.
    Abresch RT; Han JJ; Carter GT
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):7-21. PubMed ID: 19730017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.